CYP19A1 and cancer: Although estrogen deprivation can mimic the hormone withdrawal that occurs during AI treatment in clinic, this in vitro model cannot simulate the adaptive changes within cancer cells chronically treated with an AI, nor can it be employed to detect the regulatory effects of AI drugs on aromatase expression and activity.